ScripAmisulpride reached the European market as a benzamide antipsychotic in 1997 – then branded as Sanofi’s Solian – but privately held LB Pharmaceuticals has advanced a methylated formulation of the D2 r
ScripVir Biotechnology’s move from focusing solely on antiviral drugs to incorporating oncology into its pipeline has shown early signs of potentially paying off as the company announced safety and efficac
In VivoGlen Clova Scientific is a biotech startup taking a novel approach to treating chronic conditions, with a focus on debilitating skin and immune disorders. Founded in 2022 by dermatologist John Foerste
ScripThe amyotrophic lateral sclerosis (ALS) pipeline has suffered a series of setbacks recently and two separate candidates from AbbVie/Calico Life Sciences and Denali Therapeutics that have the same of m